Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis (Q48160483)

9 February 2018

title

Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis (English)

1 reference

9 February 2018

author name string

Rose JW

1

1 reference

9 February 2018

Welsh CT

2

1 reference

9 February 2018

Hill KE

3

1 reference

9 February 2018

Houtchens MK

4

1 reference

9 February 2018

Fujinami RS

5

1 reference

9 February 2018

Townsend JJ

6

1 reference

9 February 2018

publication date

1 June 1999

1 reference

9 February 2018

Journal of Neuroimmunology

published in

1 reference

9 February 2018

volume

97

1 reference

9 February 2018

issue

1-2

1 reference

9 February 2018

page(s)

110-118

1 reference

9 February 2018

Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Recovery phase of acute experimental autoimmune encephalomyelitis in rats corresponds to development of endothelial cell unresponsiveness to interferon gamma activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Integrins: versatility, modulation, and signaling in cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Anti-adhesion molecule therapy in Theiler's murine encephalomyelitis virus-induced demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Interferon-gamma-inducible endothelial cell class II major histocompatibility complex expression correlates with strain- and site-specific susceptibility to experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Competitive PCR quantification of CD4, CD8, ICAM-1, VCAM-1, and MHC class II mRNA in the central nervous system during development and resolution of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Signaling by lymphocyte function-associated antigen 1 (LFA-1) in B cells: enhanced antigen presentation after stimulation through LFA-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Leukocyte adhesion to endothelium in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Role of macrophages during Theiler's virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

ICAM-1-dependent pathway is not critically involved in the inflammatory process of autoimmune encephalomyelitis or in cytokine-induced inflammation of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1α

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900064-8

7 January 2021

10.1016/S0165-5728(99)00064-8

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018